INTRAGAM

This brand name is authorized in Hong Kong, New Zealand, Singapore, South Africa

Active ingredients

The drug INTRAGAM contains one active pharmaceutical ingredient (API):

1 Immunoglobulins, normal human, IV UNII RX2MM64U68 - HUMAN IMMUNOGLOBULINS

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects. Read about Immunoglobulins, normal human, IV

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INTRAGAM Solution for infusion	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BA02	Immunoglobulins, normal human, for intravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 46073
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14116, 8313
Country: SG	Health Sciences Authority	Identifier(s): 12022P
Country: ZA	Health Products Regulatory Authority	Identifier(s): T/30.2/740, T/30.2/741